正式發表論文90多篇(除少數幾篇之外均為第一作者或通訊作者), 其中許多文章發表在J. Med. Chem.,Curr. Med. Chem.,Curr. Pharm. Des.等國外重要雜志上。
發表英文論文:
1. Zeng HH, Zhang HB*,Synthesis and biological evaluation of fatty acids conjugates bearing cyclopentadienyl-donors incorporated [(99m)Tc/Re(CO)3](+) for myocardical imaging, Eur J Med Chem. 2014,24(72):10-7
2. Yu HJ, Fang Y, Lu X, Liu YJ, Zhang HB*,Combined 3D-QSAR, Molecular Docking, Molecular Dynamics Simulation, and Binding Free Energy Calculation Studies on the 5-Hydroxy-2H-Pyridazin-3-One Derivatives as HCV NS5B Polymerase Inhibitors, CHEMICAL BIOLOGY & DRUG DESIGN ,2014, 83: 89-105
3. Zeng HH, Zhao LZ, Hu SY, Liu YJ, Yu HJ, Chen N, Zhang HB*.,Synthesis, characterization and biodistribution of new fatty acids conjugates bearing N,N,N-donors incorporated [(99m)Tc/Re(CO)(3)](+), Dalton Trans.2013, 42(8):2894-901.
4. Lu X, Zhao LZ, Xue T, Zhang HB*, Technetium-99m- Arg-Arg-Leu(g2), a modified peptide probe targeted to neovascularization in molecular tumor imaging, J BUON. 2013 ;18(4):1074-81.
5. Hu S, Yu H, Liu Y, Xue T, Zhang H. Insight into the binding model of new antagonists of kappa receptor using docking and molecular dynamics simulation. J Mol Model. 2013,19(8):3087-94.
6. Zeng HH, Zhang HB, Wu XX, Preliminary studies of a novel cyclopentadienyl tricarbonyl technetium-99m fatty acid derivative for myocardical imaging, JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS ,2013,56(1): 1-5.
7. Liu YJ, Yu HJ, Zhao, LZ, Zhang HB*, Design and synthesis of new agents for neuronal nicotinic acetylcholine receptor (nAChRs) imaging, NUCLEAR MEDICINE AND BIOLOGY,2013, 40(1): 126-134
8. Liu YJ, Yu HJ, Zhao, LZ, Zhang HB*,Design and synthesis of new agents for neuronal nicotinic acetylcholine receptor (nAChRs) imaging, NUCLEAR MEDICINE AND BIOLOGY 40(1): 126-134,2013.
9. Zhao, Lingzhou; Liu, Yongjuan; Hu, Shiyuan; ZhangHB* , 3D-QSAR study of Chk1 kinase inhibitors based on docking, JOURNAL OF MOLECULAR MODELING,2012,18(8): 3669-3694
10. Chen Na; Liu Chunkai; Zhao Lingzhou, Zhang Huabei*, 3D-QSAR study of multi-target-directed AchE inhibitors based on autodocking, MEDICINAL CHEMISTRY RESEARCH, 21(2): 245-256,2012
11.Zeng H, Zhang H, Jang F, Zhao L, Zhang J. Molecular Modeling Studies on Benzimidazole Carboxamide Derivatives as PARP-1 Inhibitors Using 3D-QSAR and Docking, Chem Biol Drug Des. 2011,78(3):333-52.
12.Zeng Huahui; Zhang Huabei,Domestic Advances in Brain, Heart, and Tumor Radioactive Diagnosis Drugs,PROGRESS IN CHEMISTRY,2011,23(7): 1485-1492
13.Yang Yang; Zhu Lin; Chen Xiangji,Binding research on flavones as ligands of beta-amyloid aggregates by fluorescence and their 3D-QSAR, docking studies,JOURNAL OF MOLECULAR GRAPHICS & MODELLING ,2010,29( 4): 538-545
14.Yang Y, Zhu L, Cui MC, Tang RK, Zhang HB* Preparation of classical Re/Tc-99m(CO)(3)(+) and novel Tc-99m(CO)(2)(NO)(2+) cores complexed with flavonol derivatives and their binding characteristics for A beta((1-40)) aggregates,BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2010, 20( 17): 5337-5344
15.Zeng HH, Zhang HB*,Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors, JOURNAL OF MOLECULAR GRAPHICS & MODELLING,2010, 29(1), 54-71, 2010
16.Cao R, Mi N, Zhang H*. 3D-QSAR study of c-Src kinase inhibitors based on docking.J Mol Model. 2010,16(2):361-75.
17.Yang Y, Zhang JX, Zhu L, Zhang H* Synthesis, Novel Crystal Structure, and beta-Amyloid Binding Property of Re(I) (tricarbonyl) EHIDA Analogue Bioinorg Chem Appl. 2009:702730.
18.Cao R, Mi N, Zhang H*.,3D-QSAR study of c-Src kinase inhibitors based on docking.J Mol Model. 2010 Feb;16(2):361-75.
19.Yang Y, Zhu L, Zhang HB*. Di-tert-butyl 2,2'-[(2-hydroxyethyl)azanediyl] diacetate ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE 2009,65(12)3167-U1248.
20.Cao R, Zeng H, Zhang H*.,3D-QSAR studies on a series of inhibitors docked into a new homology model of the DNA-PK receptor. Curr. Pharm. Des. 2009; 15(32): 3796-825.
21.Cao HY, Cao R, Zhang HB*, Zheng XF, Gao DB,Non-nucleoside Inhibitors of NS5B Polymerase Binding to Allosteric Sites: 3D- QSAR and Molecular Docking Studies,Curr. Med. Chem., 2008,15: 1462-77.
22.Zhang HB*, Hu SP, Zhang YL. Prediction of distribution of neutral, acidic and basic structurally diverse compounds between blood and brain by the nonlinear methodology. Med Chem. 2008 , 4:170-89.
23. Zhang HB*, Li H, Ma QQ QSAR study of a large set of 3-pyridyl ethers analogues,Journal of Molecular Graphics and Modelling, 2007, 26: 226-235.
24. Cao HY, Zhang HB*,Zheng XF, Gao DB,3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family,Journal of Molecular Graphics and Modelling, 2007, 26:236-245.
25. Zhang HB*, Zhang YL, Convenient Nonlinear Model for Predicting the Tissue/Blood Partition Coefficients of Seven Human Tissues of Neutral, Acidic and Basic Structural-Diverse Compounds, J. Med. Chem., 2006,49:, 5815-5829.
26. Zhou JM, Zhou JH, Zhang HB, et al. Fluoro-substitution effects in deoxyfluoro-D-glucose derivatives: random conformational search and quantum chemical calculation , CARBOHYDRATE RESEARCH, 2006, 341: 2224-2232.
27. Zhang HB*, A QSAR Study of the Brain/Blood Partition Coefficients on the Basis of pKa Values, QSAR & combinary chemistry, 2006, 25:, 15-24. d Basic Structural-Diverse Compounds, J. Med. Chem., 2006,49(19), 5815-5829
28. Zhang HB*, A QSAR Study of the Brain/Blood Partition Coefficients on the Basis of pKa Values, QSAR & combinary chemistry, 2006, 25:, 15-24.
29. Zhang HB*, Li H, Liu CP,CoMFA, CoMSIA and Molecular Hologram QSAR Studies of Novel Neuronal nAChRs Ligands – Open Ring Analogues of 3-pyridyl Ether,J. Chem. Inf. model. 2005, 45: 440-448.
30. Zhang HB*, Ye HH, Zhang YL , et al.Synthesis, biodistribution and QSAR studies of five Tc-99m labeled novel N3S pseudo-peptide complexes, Med. Chem. Res. 2005, 14: 40-56.
31. Zhang HB*, A new approach for the tissue-blood partition coefficients of neutral and ionized compounds, J. Chem. Inf. model. 2005, 45:121-127.
32.Huabei Zhang, Haihong Ye, Yaling Zhang, Synthesis and Biological Evaluation of the Technetium-99m-labelled Five Novel N 3 S Pseudo-peptide Complexes in Mice , Med. Chem. Res., accepted for publication
33. Huabei Zhang , A New Nonlinear Equation for the Tissue/Blood Partition Coefficients of Neutral Compounds , J. Pharm.Sci., 2004, 93(6):1595-604
34. Huabei Zhang , Bo Li, Mei Dai Synthesis, Biodistribution and quantitive Structure-Activity Relationship Studies of New 99 Tc m Labeled Pseudopeptides Complexes. Applied Radiation and Isotopes , 2004, 60, 643-651
35.Huabei Zhang , Chunping Liu, Hua Li, CoMFA and COMSIA Studies of nAChRs Ligands: Epibatidine Analogous QSAR & combinary chemistry, 2004, 2004, 23 , 80-88
36. Huabei Zhang , Bo Li, Mei Dai, QSAR analysis of cationic complexes of heart perfusion imaging agents, J. Pharm. Pharmacol. 2003, 55 , 501
37.Chuan-min Qi, Ling_chuan Yang, Hua-bei Zhang ,et at Synthesis of Novel N 3 S Psedo-peptide and Biodistribution of Pseudo-peptide Complexes in Mice, Med. Chem. Res., 2003, 6, 345-359
發表中文論文:
1 Re/bmTc(CO)3+-黃酮類衍生物Aβ斑塊顯像劑的研究 楊洋; 朱霖; 張華北 中國核科學技術進展報告——中國核學會2009年學術年會論文集(第一卷•第8冊) 2009-11-18
2 環戊二烯三羰基Re/99Tcm脂肪酸心肌顯像劑的合成和生物學評價 曾華輝; 張華北 中華醫學會第九次全國核醫學學術會議論文摘要匯編 2011-08-24
3 國內心、腦、腫瘤放射性診斷藥物研究進展 曾華輝; 張華北 化學進展 2011-07-24
4 3-吡啶基醚類化合物的分子全息QSAR研究 李華; 張華北 化學學報 2005-06-15
5 抗腫瘤藥物PARP-1抑制劑及其放射性核素標記的研究進展 趙凌舟; 張華北 同位素 2011-12-20
6 關于藥物的腦血分布計算方法的研究 張雅玲; 張華北 北京師范大學學報(自然科學版) 2004-02-29
7 放射性藥物面臨的機遇與挑戰 褚泰偉; 張華北; 張俊波; 賈紅梅 核化學與放射化學 2009-07-20
8 神經型煙堿乙酰膽堿α4β2受體顯像劑研究進展 李華; 劉春萍; 張華北 中華核醫學雜志 2005-06-25
9 新煙堿型乙酰膽堿受體吡啶基醚類配體的3維定量構效關系 劉春萍; 戴梅; 張華北 北京師范大學學報(自然科學版) 2003-12-30
10 放射性核素標記靶向腫瘤新生血管分子探針研究進展 盧霞; 張華北 同位素 2013-11-20
11 Re/bTcm(CO)3+-二苯基二氮烯類化合物Aβ顯像劑的制備以及生物評價 楊洋; 崔孟超; 湯睿昆; 吳瑞; 朱霖; 張華北 同位素 2013-05-20
12 地棘蛙素類似物的CoMFA和CoMSIA的3D-QSAR研究 劉春萍; 李宏宇; 張華北 北京師范大學學報(自然科學版) 2004-04-30
13 氮對位取代基對聯吡啶與Eu(Ⅲ)絡合的影響 羊衍秋; 劉俊; 楊亮; 胡仕元; 張華北; 羅順忠 化學研究與應用 2014-10-15
14 新型煙堿型乙酰膽堿受體吡啶基醚類配體的構效關系研究 張華北; 戴梅 北京師范大學學報(自然科學版) 2002-12-30
15 煙堿型乙酰膽堿受體吡啶基胺類配體的構效關系研究 張華北; 戴梅; 劉春萍 物理化學學報 2003-09-30
16 bTcm-膦混配配合物的制備和生物分布 張華北; 李波; 齊傳民; 謝懿; 郭雪峰; 戴梅; 劉伯里 核化學與放射化學 2002-05-20
17 N2S2或N3S型配體的合成、99Tcm標記及生物分布研究 張華北; 郭雪峰; 齊傳民; 李波; 馮淑娟; 金未; 楊凌春; 劉伯里; 戴梅 核化學與放射化學 2002-11-20
18 Re/vTcm(CO)3+黃酮復合物的合成及其與Aβ斑塊的結合特性 楊洋; 劉永娟; 張華北 同位素 2011-08-20
19 新N_3S型類肽配體的合成及其小鼠體內的生物分布研究 齊傳民; 郭雪峰; 張華北; 李波; 馮淑娟; 楊凌春 藥學學報 2002-06-28
20 99Tcm-小分子多肽配合物顯像劑的合成及其在小鼠體內的生物分布研究 齊傳民; 郭雪峰; 張華北; 李波; 金未; 戴梅 藥學學報 2002-07-28
21 放射性藥物FAK抑制劑靶向腫瘤侵襲力的作用研究 盧霞; 王榮福; 張華北 腫瘤學雜志 2015-04-20
22 新N_4型酒石酸酰胺配體的合成、標記及其生物分布研究 張華北; 齊傳民; 馮淑娟; 付立民; 黃曉斌 北京師范大學學報(自然科學版) 2002-04-30
23 99Tcm-MVNE-膦混配配合物的制備及其在小鼠體內分布研究 張華北; 李波; 齊傳民; 戴梅; 郭雪峰 核技術 2003-08-10
24 [99mTc-DADS]+系列配合物的定量構效關系研究 張華北; 李波; 戴梅 北京師范大學學報(自然科學版) 2003-02-28
25 新99Tcm-膦混配配合物的制備及小鼠體內的生物分布研究 張華北; 李波; 齊傳民; 戴梅; 郭雪峰 核化學與放射化學 2003-02-20
26 一類新的99Tcm標記N_3S類肽配合物的構效關系研究 張華北; 戴梅; 齊傳民; 李波 核化學與放射化學 2003-08-20
27 99Tcm-腦顯像劑的電子結構和滯留機制的研究 張華北; 劉伯里 核化學與放射化學 1999-02-20
28 新骨架N3S型腎功能顯像劑的制備及其在小鼠體內的生物分布研究 葉海鴻; 韓見生; 劉春萍; 李華; 張華北 核技術 2005-11-10
29 [99Tcm(NO)Cl(PL)_2]+類配合物的定量構效關系 張華北; 李波; 戴梅 物理化學學報 2003-05-30
30 羰基锝-EC的制備及其生物分布研究 張華北; 李波; 戴梅; 葉海鴻; 劉春萍 核技術 2004-04-10
31 99Tcm標記N3O3-Schiff堿類配合物的定量構效關系研究 張華北; 李波; 戴梅 核化學與放射化學 2003-11-20
32 對胺基馬尿酸鹽類似物的構效關系研究 李波; 戴梅; 張華北 北京師范大學學報(自然科學版) 2003-08-30
33 99Tcm-Q類配合物的構效關系研究 張華北; 李波 核化學與放射化學 2002-08-20
34 锝化學研究?Ⅻ.99Tcm-d,l-PAO類絡合物的腦滯留能力與體外穩定性的研究 苗玉斌; 張華北; 劉伯里 同位素 1997-05-20